Evaluating comparative effectiveness of psychosocial interventions for persons receiving opioid agonist therapy for opioid use disorder: protocol for a systematic review
Introduction The opioid crisis has resulted in increasing rates of death caused by problematic opioid use. Current clinical guidelines recommend that individuals with persons with opioid use disorder (OUD) receive pharmacological (eg, opioid agonist therapy) and psychosocial (eg, cognitive behaviour...
Saved in:
Main Authors: | Brian Hutton, Beverley Shea, Kimberly Corace, David Moher, Danielle B Rice, Becky Skidmore, Kednapa Thavorn, Sheena Taha, Dianna Wolfe, Fatemeh Yazdi, Beth A Sproule, Melanie Willows, Patricia Poulin, Gary Garber, Amy Porath, Leila Esmaeilisaraji |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2018-10-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/8/10/e023902.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Psychosocial and pharmacologic interventions for problematic methamphetamine use: Findings from a scoping review of the literature.
by: Mona Hersi, et al.
Published: (2023-01-01) -
Impacts of medical and non-medical cannabis on the health of older adults: Findings from a scoping review of the literature.
by: Dianna Wolfe, et al.
Published: (2023-01-01) -
Dynamics of agonist-evoked opioid receptor activation revealed by FRET- and BRET-based opioid receptor conformation sensors
by: Sina B. Kirchhofer, et al.
Published: (2025-02-01) -
Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study
by: Anne Bouthillier, et al.
Published: (2025-02-01) -
Hospital and physician-based mental healthcare during 12 months of opioid agonist treatment for opioid use disorder: Exploring costs and factors associated with acute care.
by: Tea Rosic, et al.
Published: (2025-01-01)